Navigation Links
Cynosure Reports Financial Results for the Fourth Quarter and Full Year 2008
Date:2/10/2009

Cost of revenues 10,060 12,472 48,705 44,507 ------ ------ ------ ------ Gross profit 15,435 24,101 90,957 79,808 Operating expenses Selling and marketing 11,872 12,611 53,062 42,058 Research and development 1,891 1,869 7,497 6,827 General and administrative 6,729 2,975 17,837 11,346 ----- ----- ------ ------ Total operating expenses 20,492 17,455 78,396 60,231 (Loss) income from operations (5,057) 6,646 12,561 19,577 Interest income, net 521 754 2,498 2,516 Other (expense) income, net (98) 255 (89) 695 --- --- --- --- (Loss) income before income taxes (4,634) 7,655 14,970 22,788 Income tax (benefit) provision (2,141) 2,349 4,771 8,276 ------ ----- ----- ----- Net (loss) income $(2,493) $5,306 $10,199 $14,512 ======= ====== ======= ======= Diluted net (loss) income per share $(0.19) $0.41 $0.80 $1.15 ====== ===== ===== ===== Diluted weighted average shares outstanding 12,807 12,806 12,806 12,654 ====== ====== ====== ====== Basic net (loss) income per share $(0.20) $0.43 $0.81 $1.21 ====== ===== ===== ===== Basic weighted average shares outstanding 12,698 12,381 12,581 11,993 ====== ====== ====== ======
'/>"/>
SOURCE Cynosure, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Cynosure to Announce Fourth-quarter and Full-year 2008 Financial Results on February 10
2. Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008
3. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
4. Cynosure to Announce Second-Quarter 2008 Financial Results on July 29
5. Cynosure President and CEO Michael Davin Named Ernst & Young Entrepreneur of the Year(R) 2008 Award Winner in New England
6. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
7. Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference
8. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
9. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
10. Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
11. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 2015 , ... The Clinical Data Interchange Standards Consortium (CDISC), ... that data standards for clinical research in the areas of Schizophrenia, Hepatitis C ... These three Therapeutic Area (TA) standards were developed per the CDISC global, consensus-based ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... for people on the go. With no water needed, the refreshing berry-flavored tablets ... simple way to get the natural ingredients that may help with body detoxification, ...
(Date:7/30/2015)... ... 2015 , ... Google recently announced that it will be disclosing any incidents ... a June 8, 2015 article published by Nasdaq , the powerful tech company ... its computer-driven cars, which such industry players as Tesla CEO Elon Musk believe may ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Nursing Center,” to announce its position as one of Medicare’s top-rated care ... staff members support the CMS rating system, which monitors health inspections, staffing, ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is ... Tool That Increases Training Capability , World renown body weight trainer, Paul ... http://www.Zejax.com ), that dramatically increases a person’s training capability. , The American College ...
Breaking Medicine News(10 mins):Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2
... ... measuring and ultimately eliminating pain , ... Washington, DC (Vocus) June 4, 2010 -- Children’s National Medical Center ... the Sheikh Zayed Institute for Pediatric Surgical Innovation. Dr. Quezado joins a team of ...
... researchers say , FRIDAY, June 4 (HealthDay News) ... Wii Sports -- may help overweight seniors become more ... Although not an improvement on real-life gaming and sports ... offer a good alternative for those older individuals for ...
... Device includes ,carbon nanotubes, injected under skin, say researchers ... future, people with diabetes may be able to monitor ... This new type of continuous glucose monitor relies on ... blood sugar levels with a watch-sized or smaller monitor ...
... , ... BP to reach out for help, said Golden Age Resources, Inc. (GDAR) CFO Graham Larmer. ... Hollywood, FL (PRWEB) June ... alliance partner, Cobra Technologies, announced today the hiring of Geometrix Engineering, Inc. of Hollywood, FL ...
... so rampant last spring, will adopt a regular fall/winter pattern, ... year ago, global alarm over the emergence of an unpredictable ... Headlines blared that thousands were becoming sick; face masks and ... store shelves. , So, where is H1N1 this spring? , ...
... Dogs ... only patented product invented by a professional dog trainer. Successfully used worldwide for nine ... (used with autistic children) and Acupressure to calm dogs. Susan Sharpe, inventor, also provides ... ...
Cached Medicine News:Health News:Former NIH Chief Joins Children's National Medical Center 2Health News:Former NIH Chief Joins Children's National Medical Center 3Health News:Wii Games Can Get Seniors Moving 2Health News:Glucose 'Tattoo' Could Track Blood Sugar Levels for Diabetics 2Health News:Glucose 'Tattoo' Could Track Blood Sugar Levels for Diabetics 3Health News:Gulf Oil Spill Goes from Disaster to Catastrophe 2Health News:A Year After Its Emergence, H1N1 Swine Flu Lingers 2Health News:A Year After Its Emergence, H1N1 Swine Flu Lingers 3Health News:A Year After Its Emergence, H1N1 Swine Flu Lingers 4Health News:End Thunderstorm and Fireworks Fear with The Original Anxiety Wrap 2Health News:End Thunderstorm and Fireworks Fear with The Original Anxiety Wrap 3Health News:End Thunderstorm and Fireworks Fear with The Original Anxiety Wrap 4
(Date:7/30/2015)... 2015 Mettler-Toledo International Inc. (NYSE: MTD ... below are the highlights: , Sales in ... the prior year. Reported sales decreased 4% as currency ... , Net earnings per diluted share as reported (EPS) ... Adjusted EPS was $2.80 , an increase of ...
(Date:7/30/2015)... , July 30, 2015 IRIDEX Corporation (NASDAQ: ... its second quarter 2015 financial results after the market ... conjunction with the release, the Company will host a ... p.m. Eastern Time on Thursday, August 6, ... and other business developments. Interested parties may ...
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ ... into non-exclusive Development Agreements with Dexcom, Inc. to ... pumps with the Dexcom G5 and G6 continuous ... next generation pump platform with Dexcom,s future CGM ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... ... at ADA 2008, SAN ... announced data showing that the use of mealtime,SYMLIN(R) (pramlintide acetate) injection ... diabetes treatment goals of,improved glucose control without weight gain or hypoglycemia ...
... CAMBRIDGE, Mass., June 9 Peptimmune, Inc., ... results from its,PI-2301 peptide copolymer program at ... France and at FOCIS 2008 in Boston, ... Ia Single-Ascending-Dose, first-in-man study involving,healthy, male adult ...
Cached Medicine Technology:Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 2Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 4Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 5Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 2Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 3
... Mini-TrueView Arthroscopes,Based on the TrueView II design, ... optic telescopes for small joint arthroscopy is ... autoclavable and very durable thanks to Olympus ... new telescope class means bright images, brilliant ...
... to provide excellent protection and ease of ... being closer to an adhesive in molecular ... CoEase to maintain viscosity at high shear ... worlds for superb performance during capsulorhexis, phaco, ...
151 channels cover the entire head with a high density, with provisions for the eyes and ears. Patients and subjects are examined in a comfortable seated position or laying down....
... for evaluating a wide range of functions of ... Often referred to at the "whole body" MSI ... spinal cord and peripheral nerve studies, are expanding ... detector coils, covers a circular area approximately 32 ...
Medicine Products: